Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells

Raloxifene hydrochloride (RAL), one of second generation of selective estrogen receptor modulators (SERMs), is usually used in preventing osteoporosis and breast cancer. The present study evaluated whether Raloxifene might sensitize multidrug resistant (MDR) breast cancers to chemotherapies, especia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Biol Ther
Autores principales: Xu, Liang, Lei, Jingyu, Jiang, Donghai, Zhou, Lin, Wang, Shu, Fan, Weimin
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2015
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847829/
https://ncbi.nlm.nih.gov/pubmed/26529585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1095409
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares